Loading
  1. For founders building solutions that need to be reimbursed by payers or adopted within healthcare systems. Reimbursement is one of the biggest gating factors for adoption in healthcare. This session b …
  2. For founders building businesses that generate revenue through D2C, employer or hybrid models without relying on payer reimbursement. Your go-to-market model shapes everything your pricing, growth rat …
  3. Harness momentum that typically takes weeks of outreach and scheduling in one fast-paced, high-energy meeting block. Armed with insights from the Reverse Pitch, innovators can connect directly with th …
Build From Idea to Investment
    Focuses on the decisions founders get wrong early this session helps you ensure your product, clinical studies and data strategy support reimbursement from the outset. Learn: ' What evidence payers an …
    Covers how to design early pilots and studies that demonstrate clinical credibility, while identifying the right early adopters whether providers, employers or payers to validate your approach. Unders …
    Early-stage growth depends on having the right people around you when the pressure is high and the decisions matter most. This session explores how founders build boards and executive teams with the c …
    Legal strategy isn't a checkbox it protects your company as you grow. Get clear on how to structure IP, data governance and partnerships early, while avoiding the legal missteps that delay growth or c …
    Hear from angels, seed funds, accelerators and early-stage VCs investing in the next generation of women's health innovation. Each delivers a dynamic two-minute pitch outlining their investment criter …
Scale From Traction to Growth
    You've proven demand. Now the challenge is turning that into repeatable, system-wide growth. Learn how to structure partnerships with health systems and OB-GYN networks that move you beyond one-off de …
    Unpacking capital as a strategic tool shaping valuation, investor mix and long-term outcomes. Learn how to structure financing for scale, aligning capital with multi-year evidence and commercial miles …
    Exit is shaped long before a deal is on the table through how you build, position and evidence your company. This session teaches you how to prepare financial and clinical evidence for public markets, …
    Don't slow yourself down. Reimbursement and regulation don't operate in isolation, misalignment is one of the most common causes of delayed adoption, missed revenue and stalled growth. This session ex …
    Hear from growth investors, corporate venture arms, strategic partners and private equity funds backing companies ready to scale. Each delivers a dynamic two-minute pitch outlining their investment cr …
  1. Years of powerful advocacy, tireless research and unstoppable entrepreneurial momentum has driven the women's health industry into its next era. No longer an adjacent field, in this era of scale the h …
  2. Translating clinical value into sustainable reimbursement and adoption pathways remains one of the biggest barriers to scaling women's health innovation. Understanding how new care models fit within p …
  3. Fragmented, reactive models that fail to reflect how women experience health across their lives have an expiration date. Integrated, lifecycle-based care models that connect prevention, diagnosis and …
  4. Investment in women's health is entering a new phase marked not just by volume, but by larger, more strategic bets and increasing M&A activity across the sector. This session provides a clear view of …
  5. Sign up for series of private lunch networking discussions and roundtable activities, discover break-out companies on our tech talk stage, or head to the podcast corner to hear leading experts' though …
  6. Awards: Health Plan of the Year This award recognises the payer organisation that has gone furthest in 2026 to improve access and outcomes for its female members, through bold coverage decisions, inno …
AI & Digital Health
    As healthcare shifts toward continuous, data-driven models, the opportunity is no longer just in collecting data, but in translating it into clinically actionable insight and embedding within care del …
    Understand how healthcare systems move beyond pilot programmes to make real adoption decisions, and what criteria they use to determine whether AI solutions are ready for clinical deployment, operatio …
    Motion: This house believes that current AI systems are not yet reliable enough for widespread clinical deployment in women's health. This debate will explore: ' Whether current AI models are sufficie …
    Examine how postpartum care models are being redesigned to move beyond episodic follow-up into continuous, proactive support and what it takes to deploy these models at scale across health systems and …
    Designing a Women's Health Data Sandbox That Actually Works Dig into what it will take to build data environments that enable faster development, robust validation, and safe deployment of AI-enabled s …
    Problem: Physician burnout is at critical levels, yet many AI and digital health solutions are making workflows more complex rather than less. Tools designed to improve efficiency often add administra …
Consumer Centric Care
    Fertility care has long been defined by high costs, long wait times, and fragmented patient journeys. That model is now being challenged. A recent partnership between IVI RMA, Sesame, and Costco signa …
    As healthcare becomes a consumer market, new categories are emerging alongside established ones. Demand is accelerating across menopause care, metabolic health and GLP-1s, preventative supplements and …
    Motion: Healthcare is now a consumer-driven industry. 'Consumerisation' has become one of the most widely used narratives in healthcare. Patients have unprecedented access to information, digital plat …
    Never before have women's health decisions been made in such a complex information landscape. From social platforms and creator content to peer communities and digital tools, women are researching, co …
    Sleep is emerging as one of the most significant new opportunities in women's health. Hormones, metabolic health and menopause are increasingly linked to sleep disruption, creating demand for new diag …
    Problem: Trust is one of the biggest barriers in women's health. Despite rapid innovation, many women still struggle to know which products, platforms and providers they can rely on. Solution: Let's b …
Healthcare Costs & Models
    Your blueprint for identifying where earlier intervention and better care coordination across the female lifespan can reduce downstream costs and improve long-term financial performance. Maternity car …
    Learn where reimbursement attention is beginning to concentrate across women's health and what early lessons are emerging as organisations implement new programmes and partnerships. This panel will: ' …
    Motion: Current reimbursement models place a ceiling on progress in women's healthcare. Payment systems have historically been designed around episodic care and traditional clinical pathways, while ma …
    Learn through real-world case studies how fertility benefit programmes and care pathways are being redesigned to deliver measurable value for patients, employers and payers. Understand how redesigned …
    The conditions that drive the highest long-term costs for payers and employers - cardiovascular disease, cognitive decline, hospitalization - share a common and consistently overlooked upstream risk f …
    Understand how leaders are operationalising HEDIS measures to improve outcomes, strengthen quality performance and unlock financial incentives. Attendees will learn how organisations are: ' Translatin …
Therapeutics, Diagnostics & Med Device Innovation
    The HRT landscape is being redefined. Shifting safety narratives and evolving clinical guidance are unlocking a new phase of access, confidence, and growth. Expanding treatment to millions of underser …
    Sponsored by:
    Organon
    Gain insight from leaders across diagnostics, therapeutics, and data on how advances in hormonal, metabolic, and genetic biomarkers are enabling earlier and more precise diagnosis of PMOS. Explore how …
    Showcasing a curated group of high-potential companies developing the next generation of therapeutic assets, diagnostics, biomarkers, and precision tools for women's health. Six selected finalists wil …
    Avoid common pitfalls in early preclinical development for women's health therapeutics by generating early data that translates - strengthening asset credibility with investors, partners, and regulato …
    Drive adoption and sustained use of women's health therapies through effective clinical education and patient engagement. Even with strong clinical data and regulatory approval, many therapies underpe …
  1. A senior federal voice joins Liz Powell, one of the most experienced advocates working across Capitol Hill, to cut through the noise on what the current policy environment means for how women's health …
  2. Menopause and midlife health are rapidly moving from the margins of healthcare into the centre of commercial and clinical focus. Advances in HRT, growing employer-backed care models and increasing inv …
  3. For decades, cardiometabolic disease has sat outside the core focus of women's health. Advances in diagnostics, growing insight into sex-specific risk, and the rise of metabolic health as a clinical a …
  4. New advances are beginning to connect the dots between hormonal change, cognition and long-term neurological risk reshaping how brain health in women is understood. AI and longitudinal data are unlock …
  5. Sign up for series of private lunch networking discussions and roundtable activities, discover break-out companies on our tech talk stage, or head to the podcast corner to hear leading experts' though …
AI & Digital Health
    The Opportunities of Multi-omic Longevity Data to Personalize Women's Health Interventions Explore how multi-omic and longitudinal data are beginning to reshape prevention strategies in women's health …
    Understand how organisations are structuring data access, infrastructure, and governance to enable rapid AI development while remaining compliant with HIPAA and broader data protection requirements. T …
    Gain a clear view of where AI is delivering measurable impact across clinical development and evidence generation and how these capabilities are influencing investment decisions, trial strategy, and c …
    Explore how predictive AI is being applied to identify and manage high-risk maternal populations earlier and what it takes to translate these insights into proactive, cost-effective care models at sca …
Consumer Centric Care

    The modern patient refuses to be passive in her healthcare.

    She researches symptoms before appointments, tracks her health through digital tools, takes multiple supplements for preventative care, and arrives at consultations with clearer expectations about the care she wants to access, experience and choose. She is no longer just a patient but an empowered healthcare consumer.

    This presentation explores what this shift means for companies seeking to better reach and serve women, innovators building their next solution, employers designing benefits, and physicians caring for increasingly informed patients.

    Increasingly prescribed through telehealth and direct-to-consumer platforms, GLP-1 therapies are reshaping norms around access to prescription medicines. Surging consumer demand around these innovativ …
    Many women's health startups launch with strong intentions but struggle to build products that women actually adopt and trust. In this interactive session, participants work through common mistakes co …
    ' Navigating data licensing between apps wearables and clinical systems to create compliant and commercially viable data-sharing agreements. ' Turning consumer insights into clinically actionable sign …
Healthcare Costs & Models
    Design coverage that reflects evolving patient expectations while controlling long-term healthcare costs and workforce risk. Demand for more specialised women's health support is expanding rapidly, fr …
    Learn how payers, health systems and digital health partners are building integrated maternity care models that support women from fertility through the postpartum period while reducing costly complic …
    Reduce one of the highest-cost drivers in maternity care by identifying where early intervention can prevent preterm birth and avoid NICU admissions. Preterm birth and NICU utilisation continue to dri …
    Improve workforce retention and productivity by investing in women's health programmes that address key drivers of absenteeism, disengagement and long-term health risk. Across fertility, maternity, me …
Therapeutics, Diagnostics & Med Device Innovation
    Showcasing a curated group of high-potential companies developing the next generation of medical technologies and devices for female patients. Six selected finalists will present clinically validated, …
    For early-stage and growth-stage companies, the structure of a licensing agreement can define future valuation, partnership potential, and commercial success. Getting deal economics, IP, and exclusivi …
    Design pregnancy and lactation trials that safely generate robust, regulator-ready evidence. This presentation breaks down how to design inclusive trials that protect maternal and fetal health while m …